We read with interest the recent article by Blazeby et al. [1] , which described the implementation of decisions made by a multidisciplinary team (MDT). The study evaluated 273 decisions about patient management made at a central MDT meeting in Bristol, which assessed cases of patients with upper gastrointestinal cancer, including cases from several surrounding satellite hospitals. They found that 41 of 273 (15%) decisions about treatment made at the MDT meeting were not implemented. In the majority of cases this resulted in patients receiving a more conservative treatment than suggested by the MDT. The main reasons why decisions were not implemented were co-morbid health issues (44%), patient choice (34%) and decisions being changed when more clinical information was available (20%). In this study it was not possible to evaluate the quality of the decisions made at the MDT.
assesses all new patients seen within a particular tumour stream (e.g. lung) and educates them about the role of the MDT meeting in making treatment recommendations and when the results of the MDT discussion will be shared with the patient. This is important as it has been shown that provision of information about all treatment options can improve the mental health and well-being of adults with cancer [3] .
Secondly, the role of the MDT meeting is first to carefully assess the stage of the patient's illness and then set treatment goals appropriate to that stage. In this way an individual treatment plan can be developed in collaboration with the patient. Shared decision-making between patients and their treatment team is considered to be best practice as well as the approach preferred by most patients [4, 5] . Once a treatment plan has been established, relevant members of the MDT can be mobilised to implement the treatment plan. Although all patients will require someone to coordinate appropriate psychosocial support, the specific make-up of the team implementing the treatment will otherwise depend on the goals of care and the relevant treatment plan. This team may differ from that which initially assessed the patient as part of the MDT meeting. For example, the appropriate MDT required for decision-making and care implementation for the patient with advanced pancreatic cancer who is close to death will be different from the team required for a patient planning to undergo surgery followed by adjuvant treatment for early pancreatic cancer.
Applied in this way, multidisciplinary care should fulfil its promise of improving patient and clinician satisfaction, reducing mortality and improving patient quality of life [2] . Future research into the quality of MDT management should be encouraged. 
